Testing VS-6063 (Defactinib) as a Potential Targeted Treatment in Cancers With NF2 Genetic Changes (MATCH-Subprotocol U)
Clinical trial NCT04439331 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04439331
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-19
- Primary completion
- 2020-11-10
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.